DeborahASmithMD

PubMed

• 9 citations
  A Randomized, Placebo- and Positive-Controlled, Single-Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy S...
  Stephen Caltabiano, Jon L. Collins, Gul Serbest, Lisa A. Morgan, Deborah A. Smith, Ramiya Ravindranath, Alexander R. Cobitz> ;Clinical Pharmacology in Drug Development. 2017 Nov 1
• 7 citations
  Effect of lapatinib on oral digoxin absorption in patients.
  Kevin M. Koch, Deborah A. Smith, Jeff Botbyl, Nikita Arya, Linda P. Briley, Leanne Cartee, Jane Holshouser White, Jennifer Beyer, Mohammed M. Dar, Hyun Choel Chung, Qu...> ;Clinical Pharmacology in Drug Development. 2015 Nov 1
• 24 citations
  Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies
  Hatice Gungor, Azeem Saleem, Syed Babar, Roberto Dina, Mona El-Bahrawy, Edward Curry, Nona Rama, Michele Chen, Emily Pickford, Roshan Agarwal, Sarah P. Blagden, Sabin ...> ;Journal of Nuclear Medicine. 2015 Dec 1
• 18 citations
  Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor
  Neil L. Spector, Faith C. Robertson, Sarah S. Bacus, Kimberly L. Blackwell, Deborah A. Smith, Kelli Glenn, Leanne Cartee, Jennifer Harris, Carie L Kimbrough, Mark Gitt...> ;Plos One. 2015 Nov 16
• 92 citations
  The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
  Andrew Spencer, Sung-Soo Yoon, Simon J. Harrison, Shannon R. Morris, Deborah A. Smith, Richard A. Brigandi, Jennifer Gauvin, Rakesh Kumar, Joanna Opalinska, Christine ...> ;Blood. 2014 Oct 2
• 2 citations
  Only a Small Fraction of High-Grade Cervical Lesions Are Discovered After an Interpretation of Atypical Squamous Cells of Undetermined Significance When Using Imager-A...
  Kelly A. Khan, Debora A. Smith, Michael J. Thrall> ;Archives of Pathology & Laboratory Medicine. 2013 Jul 1
• 295 citations
  An Antibody Against IL-5 Reduces Numbers of Esophageal Intraepithelial Eosinophils in Children With Eosinophilic Esophagitis
  Amal Assa'ad, Sandeep K. Gupta, Margaret H. Collins, Mike Thomson, Amy T Heath, Deborah A. Smith, T. Perschy, Jurgensen Cynthia Holder, Hector Ortega, Seema S. Aceves> ;Gastroenterology. 2011 Nov 1
• 117 citations
  Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies
  David Olmos, Douglas Barker, Rohini Sharma, Andre T. Brunetto, Timothy A. Yap, Anne B. Taegtmeyer, Jorge Barriuso, Hanine Medani, Yan Degenhardt, Alicia Allred, Debora...> ;Clinical Cancer Research. 2011 May 15
• 61 citations
  Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody
  Deborah A. Smith, Elisabeth A. Minthorn, Misba Beerahee> ;Clinical Pharmacokinetics. 2011 Apr 1
• 396 citations
  Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
  Alex Straumann, Sébastien Conus, Pascale Grzonka, Hirohito Kita, Gail M. Kephart, Christian Bussmann, Christoph Beglinger, Deborah A. Smith, Jatin Patel, Margaret Byrn...> ;Gut. 2010 Jan 1
• 475 citations
  Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases...
  Howard A. Burris, Herbert Hurwitz, E. Claire Dees, Afshin Dowlati, Kimberly L. Blackwell, Bert H. O'Neil, Paul K. Marcom, Matthew J. Ellis, Beth Overmoyer, Suzanne F. ...> ;Journal of Clinical Oncology. 2005 Aug 10
• 14 citations
  Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled study.
  Deborah A. Smith, Elena W. Cleary, Stephanie Watkins, Cameron S. Huffman, Stacy C. Dilzer, Kenneth C. Lasseter> ;Journal of Clinical Pharmacology. 1998 Aug 1
• Join now to see all